114676-53-8

Basic information

• Product Name: D-Proline, 4-hydroxy-1-(phenylmethyl)-, methyl ester, (4R)-
• CAS NO: 114676-53-8
• Molecular Formula: C13H17NO3
• Molecular Weight: 235.283
• Mol File: 114676-53-8.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: D-Proline, 4-hydroxy-1-(phenylmethyl)-, methyl ester, (4R)-(CAS DataBase Reference)
• NIST Chemistry Reference: D-Proline, 4-hydroxy-1-(phenylmethyl)-, methyl ester, (4R)-(114676-53-8)
• EPA Substance Registry System: D-Proline, 4-hydroxy-1-(phenylmethyl)-, methyl ester, (4R)-(114676-53-8)

Safety Data

• Hazardous Substances Data: 114676-53-8(Hazardous Substances Data)

Upstream product

• 100-44-7 benzyl chloride 
• 114676-59-4 (2R,4R)-4-hydroxy-2-methoxycarbonylpyrrolidine hydrochloride 
• 100-39-0 benzyl bromide 
• 114676-47-0 (2R,4R)-4-Hydroxy-pyrrolidine-2-carboxylic acid methyl ester 
• 77449-94-6 (2R,4R)-4-hydroxypyrrolidine-2-carboxylic acid hydrochloride 
• 51-35-4 4R-4-hydroxyproline 
• 53386-64-4 methyl 2-(benzylamino)acetate 
• 2584-71-6 cis-hydroxy-D-proline 

Downstream Products

• 1562988-38-8 (S)-5-amino-3,3-difluoro-piperidine-1-carboxylic acid benzyl ester 
• 1187055-40-8 benzyl (3S)-3-(tert-butoxycarbonylamino)-5-oxo-piperidine-1-carboxylate 
• 1611481-19-6 tert-butyl ((3S,5R)-1-benzyl-5-hydroxypiperidin-3-yl)carbamate 
• 635299-91-1 (3R,5R)-1-benzyl-5-(hydroxymethyl)pyrrolidin-3-ol 
• 1611481-16-3 (2R,4R)-methyl 4-azido-1-benzylpyrrolidine-2-carboxylate 
• 1318129-67-7 (2R,4R)-methyl 1-benzyl-4-(tert-butyldiphenylsilyloxy)pyrrolidine-2-carboxylate 
• 1318128-61-8 (2R,4R)-2-(azidomethyl)-1-benzyl-4-(tert-butyldiphenylsilyloxy)pyrrolidine 
• 1318128-59-4 (3S,5R)-3-azido-1-benzyl-5-(tert-butyldiphenylsilyloxy)piperidine 
• 1318128-19-6 ((2R,4R)-1-benzyl-4-(tert-butyldiphenylsilyloxy)pyrrolidin-2-yl)methanol 
• 1271810-43-5 (3R,5S)-tert-butyl 3-azido-5-(benzoyloxy)piperidine-1-carboxylate 
• 1271806-79-1 (3'R,5'S)-1'-(6-amino-5-fiuoropyrimidin-4-yl)-3-(3-chloro-5-fluorophenylamino)-5'-fluoro-1,3'-bipiperidin-2-one 
• 1271810-19-5 (3'R,5'S)-tert-butyl 3-(3-chloro-5-fluorophenylamino)-5'-fluoro-2-oxo-1,3'-bipiperidine-1'-carboxylate 
• 1271810-13-9 tert-butyl (3R,5S)-3-amino-5-fluoro-piperidine-1-carboxylate 
• 1271810-11-7 (3R,5S)-tert-butyl 3-azido-5-fluoropiperidine-1-carboxylate 

Relevant articles and documents

DIPEPTIDE PIPERIDINE DERIVATIVES

The disclosure relates to pharmaceutical compositions, to methods of preparing such compositions, and to methods for using such compositions for treating or preventing a disease or condition associated with arginase activity.

A sub-milligram-synthesis protocol for in vitro screening of HDAC11 inhibitors

This work demonstrated the high efficiency of a sub-milligram-synthesis based medicinal chemistry method. Totally 72 compounds, consisting a tri-substituted pyrrolidine core, were prepared. Around 0.1 mg of each compound was solid-phase synthesized. Based on the additive property of UV absorptions of unconjugated chromophores of a molecule, these compounds were quantified by UV measurement. A hit, whose IC50 value was 1.2 μM in HDAC11 inhibition assays, highlights the applicability of the approach reported here in future optimization works.

COMPOUNDS

The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of or prevention of diseases characterized by LRRK2 kinase activity, for example Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis (ALS).